235 related articles for article (PubMed ID: 16164734)
1. Therapy-resistant leg ulcer caused by multiple myeloma.
Bago A; Schweiter J; Kiss M; Furesz J; Vajda A; Balo-Banga JM
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):647-8. PubMed ID: 16164734
[No Abstract] [Full Text] [Related]
2. Novel agents in first-line therapy for myeloma.
Jagannath S
Oncology (Williston Park); 2005 Nov; 19(12):1551-4. PubMed ID: 16396150
[No Abstract] [Full Text] [Related]
3. [Therapy resistant leg ulcer caused by multiple myeloma].
Bagó A; Schweitzer K; Kis M; Fúrész J; Vajda A; Baló-Banga JM
Orv Hetil; 2003 Sep; 144(37):1829-32. PubMed ID: 14596021
[TBL] [Abstract][Full Text] [Related]
4. Multiple complications in multiple myeloma.
Basi S; Schulman G; Fogo AB
Am J Kidney Dis; 2005 Mar; 45(3):619-23. PubMed ID: 15754288
[No Abstract] [Full Text] [Related]
5. Topical effectiveness of filgrastim in beta-thalassaemia leg ulcer.
Stavrianeas N; Xifteri A; Kavatha D; Vrettou H
Dermatology; 2005; 211(2):173;author reply 173. PubMed ID: 16088173
[No Abstract] [Full Text] [Related]
6. Tumor lysis syndrome following thalidomide and dexamethasone therapy for newly diagnosed multiple myeloma.
Huston A; Brown J; Roodman GD
Exp Hematol; 2006 Dec; 34(12):1616. PubMed ID: 17157156
[No Abstract] [Full Text] [Related]
7. Scar leishmaniasis.
Arfan-ul-Bari ; Simeen-ber-Rahman
J Coll Physicians Surg Pak; 2006 Apr; 16(4):294-5. PubMed ID: 16624197
[TBL] [Abstract][Full Text] [Related]
8. Amyloid deposition of systemic myeloma-associated amyloidosis excludes actinic elastotic material.
Wada N; Fujimoto N; Komatsu T; Tajima S; Ishibashi A
Eur J Dermatol; 2002; 12(6):607-8. PubMed ID: 12459542
[TBL] [Abstract][Full Text] [Related]
9. Two cases of plasma cell leukemia with atypical immunophenotype.
Buda G; Carulli G; Orciuolo E; Cannizzo E; Zucca A; Azzarà A; Rossi A; Galimberti S; Cecconi N; Petrini M
Acta Haematol; 2007; 118(1):27-9. PubMed ID: 17429194
[No Abstract] [Full Text] [Related]
10. Myeloma bone disease: pathogenesis and treatment.
Roodman GD;
Oncology (Williston Park); 2005 Jul; 19(8):983-4, 986. PubMed ID: 16131042
[TBL] [Abstract][Full Text] [Related]
11. Reply. Kastritis E. et al. Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone containing regimes and the impact of novel agents. Haematologica 2007; 92:546-9.
Bergner R; Hoffmann M; Uppenkamp M
Haematologica; 2008 Jan; 93(1):e18-9. PubMed ID: 18166771
[No Abstract] [Full Text] [Related]
12. Non-secretory multiple myeloma with hypercalcemic acute renal failure.
Prakash MS; Baliga KV; Singh AP; Mishra DK
J Assoc Physicians India; 2002 Oct; 50():1330-1. PubMed ID: 12568228
[No Abstract] [Full Text] [Related]
13. Severe ulcerative panniculitis caused by alpha 1-antitrypsin deficiency: remission induced and maintained with intravenous alpha 1-antitrypsin.
Al-Niaimi F; Lyon C
J Am Acad Dermatol; 2011 Jul; 65(1):227-9. PubMed ID: 21679830
[No Abstract] [Full Text] [Related]
14. Bulbar palsy in multiple myeloma.
Chim CS; Ooi GC
Haematologica; 2005 Dec; 90(12 Suppl):ECR42. PubMed ID: 16464757
[No Abstract] [Full Text] [Related]
15. Guidelines on the diagnosis and management of multiple myeloma 2005.
Smith A; Wisloff F; Samson D; ; ;
Br J Haematol; 2006 Feb; 132(4):410-51. PubMed ID: 16412016
[No Abstract] [Full Text] [Related]
16. Severe leg ulcers in a multiple myeloma patient with cryoglobulinemic vasculitis.
Jiménez-Encarnación E; García-Pallas MV; Vilá LM
P R Health Sci J; 2012 Jun; 31(2):71. PubMed ID: 22783699
[No Abstract] [Full Text] [Related]
17. Clinical approach to atypical wounds with a new model for understanding hypertensive ulcers.
Shelling ML; Federman DG; Kirsner RS
Arch Dermatol; 2010 Sep; 146(9):1026-9. PubMed ID: 20855705
[No Abstract] [Full Text] [Related]
18. [Meningitis caused by Listeria monocytogenes in the patient with multiple myeloma].
Pokrovskaia OS; Mendeleeva LP; Gribanova EO; Ustinova EN; Kliasova GA; Sharikova OA; Galstian GM; Iatskov KV; Varlamova EIu; Kaplanskaia IB
Ter Arkh; 2003; 75(7):76-8. PubMed ID: 12934487
[No Abstract] [Full Text] [Related]
19. Low-dose tissue plasminogen activator for calciphylaxis.
Sewell LD; Weenig RH; Davis MD; McEvoy MT; Pittelkow MR
Arch Dermatol; 2004 Sep; 140(9):1045-8. PubMed ID: 15381542
[No Abstract] [Full Text] [Related]
20. Cutaneous involvement in multiple myeloma and bortezomib.
Siniscalchi A; Fratoni S; Santeusanio G; Del Poeta G; de Fabritiis P; Caravita T
Ann Hematol; 2009 Nov; 88(11):1137-9. PubMed ID: 19259673
[No Abstract] [Full Text] [Related]
[Next] [New Search]
